Back to Search
Start Over
Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, M pro and PL pro of SARS-CoV-2: Protein-Protein Interactions, Dynamics Simulations and Free Energy Calculations.
- Source :
-
Molecules (Basel, Switzerland) [Molecules] 2021 Aug 24; Vol. 26 (17). Date of Electronic Publication: 2021 Aug 24. - Publication Year :
- 2021
-
Abstract
- The emergence of COVID-19 continues to pose severe threats to global public health. The pandemic has infected over 171 million people and claimed more than 3.5 million lives to date. We investigated the binding potential of antiviral cyanobacterial proteins including cyanovirin-N, scytovirin and phycocyanin with fundamental proteins involved in attachment and replication of SARS-CoV-2. Cyanovirin-N displayed the highest binding energy scores (-16.8 ± 0.02 kcal/mol, -12.3 ± 0.03 kcal/mol and -13.4 ± 0.02 kcal/mol, respectively) with the spike protein, the main protease (M <superscript>pro</superscript> ) and the papainlike protease (PL <superscript>pro</superscript> ) of SARS-CoV-2. Cyanovirin-N was observed to interact with the crucial residues involved in the attachment of the human ACE2 receptor. Analysis of the binding affinities calculated employing the molecular mechanics-Poisson-Boltzmann surface area (MM-PBSA) approach revealed that all forms of energy, except the polar solvation energy, favourably contributed to the interactions of cyanovirin-N with the viral proteins. With particular emphasis on cyanovirin-N, the current work presents evidence for the potential inhibition of SARS-CoV-2 by cyanobacterial proteins, and offers the opportunity for in vitro and in vivo experiments to deploy the cyanobacterial proteins as valuable therapeutics against COVID-19.
- Subjects :
- Antiviral Agents therapeutic use
Bacterial Proteins therapeutic use
Bacterial Proteins ultrastructure
COVID-19 virology
Coronavirus 3C Proteases antagonists & inhibitors
Coronavirus 3C Proteases metabolism
Coronavirus 3C Proteases ultrastructure
Coronavirus Papain-Like Proteases antagonists & inhibitors
Coronavirus Papain-Like Proteases metabolism
Coronavirus Papain-Like Proteases ultrastructure
Coronavirus Protease Inhibitors therapeutic use
Coronavirus Protease Inhibitors ultrastructure
Humans
Molecular Docking Simulation
Molecular Dynamics Simulation
Protein Binding
Protein Interaction Mapping
Spike Glycoprotein, Coronavirus antagonists & inhibitors
Spike Glycoprotein, Coronavirus metabolism
Spike Glycoprotein, Coronavirus ultrastructure
X-Ray Diffraction
Antiviral Agents pharmacology
Bacterial Proteins pharmacology
Coronavirus Protease Inhibitors pharmacology
COVID-19 Drug Treatment
Subjects
Details
- Language :
- English
- ISSN :
- 1420-3049
- Volume :
- 26
- Issue :
- 17
- Database :
- MEDLINE
- Journal :
- Molecules (Basel, Switzerland)
- Publication Type :
- Academic Journal
- Accession number :
- 34500548
- Full Text :
- https://doi.org/10.3390/molecules26175114